Planned Parenthood Federation: Lawsuit Asks FDA to Remove Medically Unnecessary Barriers to Reproductive Health Care During COVID-19
June 20, 2020
June 20, 2020
NEW YORK, June 20 -- The Planned Parenthood Federation of America issued the following statement by Acting President Alexis McGill Johnson:
A federal court in Maryland will hear arguments in a lawsuit asking the U.S. Food and Drug Administration (FDA) to temporarily ease restrictions on on the medication mifepristone, in order to ensure patients can safely access abortion and miscarriage care during the COVID-19 pandemic. The suit was filed by the American Civil Liberties Union (ACL . . .
A federal court in Maryland will hear arguments in a lawsuit asking the U.S. Food and Drug Administration (FDA) to temporarily ease restrictions on on the medication mifepristone, in order to ensure patients can safely access abortion and miscarriage care during the COVID-19 pandemic. The suit was filed by the American Civil Liberties Union (ACL . . .